Methods for improving drug release from poly(methyl)methacrylate bone cement.
Poly(methylmethacrylate) (PMMA) is a widely used material with both dental and orthopaedic applications.  The acrylic cement is produced by the combination of polymethylacrylate beads with methylmethacrylate monomer.  After polymerisation, a heterogeneous and porous matrix is formed which can be used to deliver therapeutic agents. In this work, the release of antibiotic, growth hormone and serum albumin is demonstrated.  The mechanism is similar for all agents; a rapid release followed by a slow continuous release.  The quantity of drug released depends upon the formulation of both the PMMA and the drug.  The polymer-to-monomer ratio can greatly affect the ratio of drug release; increased polymer-to-monomer ratio leads to increased release of antibiotic.  Optimum release is achieved if a crystalline formulation of the drug is used rather than a fine powder.  Experimental methods to improve the drug release performance of bone cements are presented.
Downes
S
S
Institute of Orthopaedics, Stanmore, Middlesex, UK.
D001843:Bone Cements / Q000737:chemistry; D016503:Drug Delivery Systems; D005839:Gentamicins / Q000737:chemistry; D013006:Growth Hormone / Q000737:chemistry; D006801:Humans; D008768:Methylmethacrylates / Q000737:chemistry; D012710:Serum Albumin, Bovine / Q000737:chemistry